ClinicalTrials.gg

Resilient Pharmaceuticals clinical trials

Also known as Lykos, MAPS PBC.

Its pipeline, or its studies — you choose. Free with an account during the beta.

The registry lists 30 studies whose lead sponsor is Resilient Pharmaceuticals or one of 1 company grouped under it. 1 are recruiting or about to start. Per ClinicalTrials.gov, last updated Jun 29, 2026.

Our grouping of 2 registry names, not the registry’s. See them and correct one ↓

Pipeline: 1 program

Each counted once: 1 with a study Resilient Pharmaceuticals leads registered in the last two years.

  • Phase 3

The 1 phase-3 program — sign in to see them, free: with every program, filter by condition or phase and sort by first study or primary completion.

“Registry” is the highest phase of Resilient Pharmaceuticals’ own registered studies; Resilient Pharmaceuticals’ own pipeline document is not read yet. “Primary completion” is the earliest date still ahead among its live studies when the main measure’s data collection ends, as the registry states it (most are estimates); results come later, if they are announced. Programs are read from ClinicalTrials.gov, joined across names by rules and decisions each recorded with its evidence.

What it is testing

The drugs Resilient Pharmaceuticals’ studies test, most open studies first — 1 drug with a page of their own. Each count opens the studies in search.

Open now Not open: under way, finished or stopped

All 30 at a glance

Where each study is in its life, its phase and its countries. Each count opens them in search.

  • Open now13%
  • Under way, not recruiting13%
  • Completed2067%
  • Stopped early723%Withdrawn 4 · Terminated 3
  • Status unknown or other13%

Phase

  • Phase 217
  • Phase 17
  • Phase 33

Where

  • United States21
  • Israel6
  • Canada5
  • Switzerland1

Over the years

  1. 07
  2. 08
  3. 09
  4. 10
  5. 11
  6. 12
  7. 13
  8. 314
  9. 15
  10. 16
  11. 17
  12. 18
  13. 19
  14. 20
  15. 21
  16. 22
  17. 23
  18. 24
  19. 25
  20. 326

By the year each study started; 2 started before 2007. 2026 so far in the lighter column.

Registry sponsor names on this page

Our grouping. This page groups the registry's lead sponsor names by company — our grouping, not the registry's. It can be wrong or incomplete: an acquired company whose name never mentions its owner may be missing. Use “Something wrong?” under any name below to correct it.

Tell us about a missing company
No account needed. Please leave out personal details.

Each name exactly as ClinicalTrials.gov lists it, and how it relates to Resilient Pharmaceuticals.

  • Lykos Therapeutics
    Subsidiary
    Something wrong?
    What is wrong with this name?
    No account needed. Please leave out personal details.
    28 studies →
  • Resilient Pharmaceuticals
    Same company
    Something wrong?
    What is wrong with this name?
    No account needed. Please leave out personal details.
    2 studies

Focus areas

Conditions Resilient Pharmaceuticals leads ten or more studies in, by study count. A broader condition is left out when almost all its studies are already in a narrower one listed here.

Studies

Recruiting first, then most recently updated. Showing 30 of 30.